Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
FidoCure®
AddedMar 17, 2024
UpdatedJul 17, 2026
FidoCure®

FidoCure®

Series Unknown

FidoCure®: Leading Precision Medicine for Dogs with Cancer, Partnering with 143+ Clinics Nationwide.

HQ
Palo Alto, CA, US
Founded
2016
Accelerator
Y Combinator logoY CombinatorW18
Overview
Compare
Fundraising
Employees
Website

Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine. rnrnFidoCure® empowers veterinarians to offer genetic sequencing and targeted therapies to treat dogs with cancer.

We are committed to expanding the veterinary oncology toolbox for both diagnostics and therapeutics. rnrnOur veterinary partners have treated thousands of dogs over the past 30 years and work closely with the growing FidoCure® network of over 143 clinics and 180 forward-thinking veterinary oncologists throughout the US.rnrnTogether, we can combat canine cancer!

FidoCure® - Similar Companies

PetDx logo

PetDx

Curelab Veterinary logo

Curelab Veterinary

Elias Animal Health logo

Elias Animal Health

Embark Veterinary logo

Embark Veterinary

embarkvet.com

Vetigenics logo

Vetigenics

vetigenics.com

Felix&Fido logo

Felix&Fido

felixandfido.com

VetDC logo

VetDC

Cure Forward logo

Cure Forward

Dr.Tail logo

Dr.Tail

drtail.us

Oncotect logo

Oncotect

oncotect.co

Dog Health Scout logo

Dog Health Scout

doghealthscout.com

Leah Labs logo

Leah Labs

leahlabs.com

Loyal logo

Loyal

loyalfordogs.com

xCures logo

xCures

xcures.com

Obe Digital Pet Health & Wellness logo

Obe Digital Pet Health & Wellness

FidoCure® - Quick Facts

Who are FidoCure®'s competitors?

Companies similar to FidoCure® include PetDx, Curelab Veterinary, Elias Animal Health and Embark Veterinary.

When was FidoCure® founded?

FidoCure® was founded in 2016.

Where is FidoCure®'s headquarters located?

FidoCure®'s headquarters is located in Palo Alto, CA, US.

How much has FidoCure® raised to-date?

As of Jul 19, 2022, FidoCure® has raised a total of $15.1M (USD).

How many employees does FidoCure® have?

FidoCure® has 34 employees as of Feb 4, 2024.

FidoCure® - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • SaaS
Main Product
  • Cancer Treatment
  • Genetic Sequencing
Tags
  • Healthtech
  • Pet Tech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 13 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541940Veterinary Services
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541900Other Professional, Scientific, and Technical Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 700Agricultural Services
  • 740Veterinary Services
  • 7300Business Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research